Business Services
Medical
Health
Myomo
$1.209876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.06 (-4.80%) Today
+$0.01 (0.84%) After Hours
Why Robinhood?
You can buy or sell Myomo and other stocks, options, ETFs, and crypto commission-free!
About
Myomo Inc., also called Myomo, is a medical robotics company, which offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It offers MyoPro, which is a myoelectric elbow/wrist/hand orthosis that supports an impaired hand and arm while also enabling it to move again. Read More The company was founded by Stephen Kelly, John McBean, Mira Sahney and Kailas N. Narendran on September 1, 2004 and is headquartered in Cambridge, MA.
Employees
45
Headquarters
Cambridge, Massachusetts
Founded
2004
Market Cap
15.56M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
213.16K
High Today
$1.25
Low Today
$1.20
Open Price
$1.21
Volume
29.59K
52 Week High
$4.30
52 Week Low
$1.15
Collections
Business Services
Medical
Health
2017 IPO
US
North America
News
Simply Wall StMar 12
Myomo, Inc. (NYSEMKT:MYO): Are Analysts Bullish?
Myomo, Inc.’s (NYSEMKT:MYO) most recent earnings update in December 2018 signalled company earnings became less negative compared to the previous year’s level – great news for investors Below is my commentary, albeit very simple and high-level, on how market analysts perceive Myomo’s earnings growth trajectory over the next few years and whether the future looks brighter. Note that I will be looking at net income excluding extraordinary items to get a better understanding of the underlying drivers of earnin...
Seeking AlphaMar 7
Myomo's (MYO) CEO Paul Gudonis on Q4 2018 Results - Earnings Call Transcript
Myomo, Inc. (NYSEMKT:MYO) Q4 2018 Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants Vivian Cervantes – Investor Relations Paul Gudonis – Chairman and Chief Executive Officer David Henry – Chief Financial Officer Conference Call Participants Jim Sidoti – Sidoti & Company Scott Henry – ROTH Capital Paul Bienstock – National Securities Roger Duan – RF Lafferty & Co., Inc. Operator Good day, and welcome to the Myomo, Inc. Fourth Quarter Earnings Conference Call. All participants ...
BusinessWireFeb 28
Myomo to Report Fourth Quarter and Year End 2018 Results on March 7, 2019
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2018 on Thursday, March 7, 2019, after the US markets close. The Company will host a conference call on Thursday, March 7, 2019 at 4:30 p.m. EST featuring rema...
Price Paid on Robinhood
54% Lower
Right Now
52 Week Low
$1.15
Average Price Paid
$2.63
52 Week High
$4.30
Earnings
-$0.23
-$0.22
-$0.21
-$0.20
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 8, After Hours